A Multicenter, Randomized, Open-Label, Parallel Group Phase 1 Pharmacokinetic Comparability Study of Benralizumab Administrated Using Accessorized Pre-Filled Syringe (APFS) or Autoinjector (AI) in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 24 Jul 2017 Status changed from active, no longer recruiting to completed.
- 08 Jun 2017 Planned End Date changed from 26 Jun 2017 to 7 Jul 2017.
- 08 Jun 2017 Planned primary completion date changed from 26 Jun 2017 to 7 Jul 2017.